Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA

Proceedings of the National Academy of Sciences of the United States of America - Tập 101 Số 51 - Trang 17765-17770 - 2004
Michael T. Barrett1, Alicia Scheffer1, Amir Ben‐Dor1, Nick Sampas1, Doron Lipson1, Robert Kincaid1, Peter Tsang1, Bo Curry1, Kristin Baird1, Paul S. Meltzer1, Zohar Yakhini1, Laura Clarke1, Stephen Laderman1
1Agilent Technologies, 3500 Deer Creek Road, Palo Alto, CA 94304; and Cancer Genetics Branch, National Human Genome Research Institute, Bethesda, MD 20892

Tóm tắt

Array-based comparative genomic hybridization (CGH) measures copy-number variations at multiple loci simultaneously, providing an important tool for studying cancer and developmental disorders and for developing diagnostic and therapeutic targets. Arrays for CGH based on PCR products representing assemblies of BAC or cDNA clones typically require maintenance, propagation, replication, and verification of large clone sets. Furthermore, it is difficult to control the specificity of the hybridization to the complex sequences that are present in each feature of such arrays. To develop a more robust and flexible platform, we created probe-design methods and assay protocols that make oligonucleotide microarrays synthesized in situ by inkjet technology compatible with array-based comparative genomic hybridization applications employing samples of total genomic DNA. Hybridization of a series of cell lines with variable numbers of X chromosomes to arrays designed for CGH measurements gave median ratios for X-chromosome probes within 6% of the theoretical values (0.5 for XY/XX, 1.0 for XX/XX, 1.4 for XXX/XX, 2.1 for XXXX/XX, and 2.6 for XXXXX/XX). Furthermore, these arrays detected and mapped regions of single-copy losses, homozygous deletions, and amplicons of various sizes in different model systems, including diploid cells with a chromosomal breakpoint that has been mapped and sequenced to a precise nucleotide and tumor cell lines with highly variable regions of gains and losses. Our results demonstrate that oligonucleotide arrays designed for CGH provide a robust and precise platform for detecting chromosomal alterations throughout a genome with high sensitivity even when using full-complexity genomic samples.

Từ khóa


Tài liệu tham khảo

10.1038/2524

10.1038/12640

10.1038/ng754

10.1101/gr.1847304

10.1038/ng771

10.1126/science.274.5287.610

10.1038/nbt1296-1675

10.1038/86730

10.1038/ng1296-441

10.1038/79269

10.1038/nbt869

Gray J. W. Pinkel D. Albertson D. Collins C. & Baldocchi R. (1999) U.S. Patent US6465182.

Wigler M. & Lucito R. (1998) U.S. Patent US9823168.

10.1101/gr.1349003

10.1158/0008-5472.CAN-03-3308

10.1101/gr.2012304

Jankowski, S. A., Mitchell, D. S., Smith, S. H., Trent, J. M. & Meltzer, P. S. (1994) Oncogene 9, 1205-1211.8134123

Fritz, B., Schubert, F., Wrobel, G., Schwaenen, C., Wessendorf, S., Nessling, M., Korz, C., Rieker, R. J., Montgomery, K., Kucherlapati, R., et al. (2002) Cancer Res. 62, 2993-2998.12036902

Reifenberger, G., Ichimura, K., Reifenberger, J., Elkahloun, A. G., Meltzer, P. S. & Collins, V. P. (1996) Cancer Res. 56, 5141-5145.8912848

10.1002/gcc.1143

10.1093/hmg/8.1.87

Paige, J. W., Taylor, K. J., Stewart, A., Sgouros, J. G., Gabra, H., Sellar, G. C., Smyth, J. F., Porteous, D. J. & Watson, J. E. V. (2000) Cancer Res. 60, 1690-1697.10749141

10.1093/hmg/ddg261

10.1038/sj.onc.1204611

10.1093/nar/gnh069

10.1073/pnas.0533805100

Thông tin
Thông tin xuất bản

Proceedings of the National Academy of Sciences of the United States of America

Tập 101 Số 51

17765-17770

Thông tin tác giả